Sciwind Biosciences is a clinical-stage biopharmaceutical company focused on developing innovative therapies for metabolic diseases. Its lead asset, ecnoglutide (XW003), is currently in the NDA stage in China. Leveraging proprietary platforms for oral peptide and long-acting protein therapeutics, Sc... Read more
Org chart
Collapse
No reports!
Teams
This company has no teams yet
Offices
This company has no offices yet
